Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Viridian Therapeutics Inc (NASDAQ: VRDN) closed the day trading at $20.19 up 5.82% from the previous closing price of $19.08. In other words, the price has increased by $5.82 from its previous closing price. On the day, 0.63 million shares were traded. VRDN stock price reached its highest trading level at $20.46 during the session, while it also had its lowest trading level at $18.92.
Ratios:
For a better understanding of VRDN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.01 and its Current Ratio is at 11.01. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
On December 19, 2024, Wells Fargo Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $37 to $27.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRDN now has a Market Capitalization of 1648763264 and an Enterprise Value of 1297373184. For the stock, the TTM Price-to-Sale (P/S) ratio is 5495.87 while its Price-to-Book (P/B) ratio in mrq is 5.05. Its current Enterprise Value per Revenue stands at 4253.683 whereas that against EBITDA is -3.496.
Stock Price History:
The Beta on a monthly basis for VRDN is 0.52, which has changed by -0.11252749 over the last 52 weeks, in comparison to a change of 0.1529237 over the same period for the S&P500. Over the past 52 weeks, VRDN has reached a high of $27.20, while it has fallen to a 52-week low of $9.90. The 50-Day Moving Average of the stock is 10.28%, while the 200-Day Moving Average is calculated to be 22.95%.
Shares Statistics:
Over the past 3-months, VRDN traded about 768.88K shares per day on average, while over the past 10 days, VRDN traded about 649270 shares per day. A total of 81.65M shares are outstanding, with a floating share count of 73.55M. Insiders hold about 9.93% of the company’s shares, while institutions hold 106.21% stake in the company. Shares short for VRDN as of 1757894400 were 11000468 with a Short Ratio of 14.31, compared to 1755216000 on 11787624. Therefore, it implies a Short% of Shares Outstanding of 11000468 and a Short% of Float of 14.069999999999999.
Earnings Estimates
Viridian Therapeutics Inc (VRDN) is presently subject to a detailed evaluation by 11.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$1.06, with high estimates of -$0.42 and low estimates of -$1.36.
Analysts are recommending an EPS of between -$2.96 and -$4.97 for the fiscal current year, implying an average EPS of -$4.05. EPS for the following year is -$3.97, with 11.0 analysts recommending between -$2.9 and -$4.99.
